176 related articles for article (PubMed ID: 26233784)
21. Cefazolin bolus and continuous administration for elective cardiac surgery: improved pharmacokinetic and pharmacodynamic parameters.
Adembri C; Ristori R; Chelazzi C; Arrigucci S; Cassetta MI; De Gaudio AR; Novelli A
J Thorac Cardiovasc Surg; 2010 Aug; 140(2):471-5. PubMed ID: 20570290
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics of cefazolin prophylaxis in obese gravidae at time of cesarean delivery.
Young OM; Shaik IH; Twedt R; Binstock A; Althouse AD; Venkataramanan R; Simhan HN; Wiesenfeld HC; Caritis SN
Am J Obstet Gynecol; 2015 Oct; 213(4):541.e1-7. PubMed ID: 26103528
[TBL] [Abstract][Full Text] [Related]
23. Surgical site infection rate is higher following hip and knee arthroplasty when cefazolin is underdosed.
Morris AJ; Roberts SA; Grae N; Frampton CM
Am J Health Syst Pharm; 2020 Mar; 77(6):434-440. PubMed ID: 31950139
[TBL] [Abstract][Full Text] [Related]
24. Outcome of cefazolin prophylaxis for total knee arthroplasty at an institution with high prevalence of methicillin-resistant Staphylococcus aureus infection.
Song KH; Kang YM; Sin HY; Yoon SW; Seo HK; Kwon S; Shin MJ; Chang CB; Kim TK; Kim HB
Int J Infect Dis; 2011 Dec; 15(12):e867-70. PubMed ID: 22019197
[TBL] [Abstract][Full Text] [Related]
25. A pilot study to determine the feasibility of continuous cefazolin infusion.
Waltrip T; Lewis R; Young V; Farmer M; Clayton S; Myers S; Gray LA; Galandiuk S
Surg Infect (Larchmt); 2002; 3(1):5-9. PubMed ID: 12593694
[TBL] [Abstract][Full Text] [Related]
26. Does current cefazolin dosing achieve adequate tissue and blood concentrations in obese women undergoing cesarean section?
Kram JJF; Greer DM; Cabrera O; Burlage R; Forgie MM; Siddiqui DS
Eur J Obstet Gynecol Reprod Biol; 2017 Mar; 210():334-341. PubMed ID: 28122314
[TBL] [Abstract][Full Text] [Related]
27. Surgical Site Infection After Arthroplasty: Comparative Effectiveness of Prophylactic Antibiotics: Do Surgical Care Improvement Project Guidelines Need to Be Updated?
Ponce B; Raines BT; Reed RD; Vick C; Richman J; Hawn M
J Bone Joint Surg Am; 2014 Jun; 96(12):970-977. PubMed ID: 24951731
[TBL] [Abstract][Full Text] [Related]
28. Cefazolin dosing for surgical prophylaxis in morbidly obese patients.
Ho VP; Nicolau DP; Dakin GF; Pomp A; Rich BS; Towe CW; Barie PS
Surg Infect (Larchmt); 2012 Feb; 13(1):33-7. PubMed ID: 22316145
[TBL] [Abstract][Full Text] [Related]
29. Cefazolin tissue concentrations with a prophylactic dose administered before sleeve gastrectomy in obese patients: a single centre study in 116 patients.
Cinotti R; Dumont R; Ronchi L; Roquilly A; Atthar V; Grégoire M; Planche L; Letessier E; Dailly E; Asehnoune K
Br J Anaesth; 2018 Jun; 120(6):1202-1208. PubMed ID: 29793587
[TBL] [Abstract][Full Text] [Related]
30. Higher cefazolin concentrations in synovial fluid with intraosseous regional prophylaxis in knee arthroplasty: a randomized controlled trial.
Zhang J; Chen G; Yu X; Liu Y; Li Z; Zhang X; Zhong Q; Xu R
Arch Orthop Trauma Surg; 2023 Oct; ():. PubMed ID: 37902891
[TBL] [Abstract][Full Text] [Related]
31. ANTIBIOTIC PROPHYLAXIS IN BARIATRIC SURGERY: a continuous infusion of cefazolin versus ampicillin/sulbactam and ertapenem.
Ferraz ÁA; Siqueira LT; Campos JM; Araújo GC; Martins Filho ED; Ferraz EM
Arq Gastroenterol; 2015; 52(2):83-7. PubMed ID: 26039823
[TBL] [Abstract][Full Text] [Related]
32. CORR Insights(®): Regional Intraosseous Administration of Prophylactic Antibiotics is More Effective Than Systemic Administration in a Mouse Model of TKA.
Zalavras CG
Clin Orthop Relat Res; 2015 Nov; 473(11):3585-7. PubMed ID: 26293224
[No Abstract] [Full Text] [Related]
33. Use of regional administration of prophylactic antibiotics in total knee arthroplasty.
Symonds T; Parkinson B; Hazratwala K; McEwen P; Wilkinson M; Grant A
ANZ J Surg; 2018 Sep; 88(9):848-853. PubMed ID: 30151929
[TBL] [Abstract][Full Text] [Related]
34. Intraosseous Versus Intravenous Vancomycin in Tourniquetless Primary Total Knee Arthroplasty: A Randomized Trial.
Wininger AE; Gurusamy P; Sullivan TC; Serpelloni S; Taraballi F; Park KJ; Brown TS
J Arthroplasty; 2024 Mar; ():. PubMed ID: 38462143
[TBL] [Abstract][Full Text] [Related]
35. Prospective randomized comparison of single-dose versus 1-day cefazolin for prophylaxis in gynecologic surgery.
Su HY; Ding DC; Chen DC; Lu MF; Liu JY; Chang FY
Acta Obstet Gynecol Scand; 2005 Apr; 84(4):384-9. PubMed ID: 15762971
[TBL] [Abstract][Full Text] [Related]
36. Intraosseous Administration of Medications in Total Knee Arthroplasty: An Opportunity for Improved Outcomes and Superior Compliance.
Harper KD; Incavo SJ
JBJS Essent Surg Tech; 2024; 14(2):. PubMed ID: 38779408
[TBL] [Abstract][Full Text] [Related]
37. Antibiotic prophylaxis and tourniquet inflation in total knee arthroplasty.
Friedman RJ; Friedrich LV; White RL; Kays MB; Brundage DM; Graham J
Clin Orthop Relat Res; 1990 Nov; (260):17-23. PubMed ID: 2121406
[TBL] [Abstract][Full Text] [Related]
38. Lack of Pharmacokinetic Basis of Weight-Based Dosing and Intra-Operative Re-Dosing with Cefazolin Surgical Prophylaxis in Obese Patients: Implications for Antibiotic Stewardship.
Blum S; Cunha CB; Cunha BA
Surg Infect (Larchmt); 2019 Sep; 20(6):439-443. PubMed ID: 31112072
[TBL] [Abstract][Full Text] [Related]
39. Cefazolin prophylaxis in obese women undergoing cesarean delivery: a randomized controlled trial.
Maggio L; Nicolau DP; DaCosta M; Rouse DJ; Hughes BL
Obstet Gynecol; 2015 May; 125(5):1205-1210. PubMed ID: 25932849
[TBL] [Abstract][Full Text] [Related]
40. Timing of surgical antibiotic prophylaxis and the risk of surgical site infection.
Hawn MT; Richman JS; Vick CC; Deierhoi RJ; Graham LA; Henderson WG; Itani KM
JAMA Surg; 2013 Jul; 148(7):649-57. PubMed ID: 23552769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
